Ohio Public Employees Retirement System (OPERS)’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,905
Closed -$75K 2041
2020
Q3
$75K Sell
23,905
-3,866
-14% -$12.3K ﹤0.01% 1571
2020
Q2
$81K Sell
27,771
-5,051
-15% -$16K ﹤0.01% 1540
2020
Q1
$93K Sell
32,822
-913
-3% -$2.94K ﹤0.01% 1429
2019
Q4
$109K Sell
33,735
-884
-3% -$2.57K ﹤0.01% 1513
2019
Q3
$75K Sell
34,619
-2,951
-8% -$7.89K ﹤0.01% 1712
2019
Q2
$118K Sell
37,570
-2,828
-7% -$9.17K ﹤0.01% 1595
2019
Q1
$150K Sell
40,398
-3,240
-7% -$10.9K ﹤0.01% 1554
2018
Q4
$127K Sell
43,638
-2,731
-6% -$7.5K ﹤0.01% 1462
2018
Q3
$122K Sell
46,369
-29,318
-39% -$72K ﹤0.01% 1577
2018
Q2
$177K Sell
75,687
-1,660
-2% -$4.63K ﹤0.01% 1531
2018
Q1
$227K Sell
77,347
-19,240
-20% -$52.5K ﹤0.01% 1488
2017
Q4
$265K Buy
96,587
+28,884
+43% +$88.7K ﹤0.01% 1473
2017
Q3
$230K Buy
67,703
+2,091
+3% +$5.81K ﹤0.01% 1494
2017
Q2
$162K Buy
65,612
+10,189
+18% +$23.4K ﹤0.01% 1536
2017
Q1
$126K Buy
55,423
+7,336
+15% +$16.2K ﹤0.01% 1582
2016
Q4
$110K Sell
48,087
-112,816
-70% -$315K ﹤0.01% 1629
2016
Q3
$539K Buy
160,903
+124,803
+346% +$396K ﹤0.01% 1279
2016
Q2
$113K Buy
36,100
+6,809
+23% +$22.7K ﹤0.01% 1531
2016
Q1
$98K Buy
29,291
+4,294
+17% +$13.4K ﹤0.01% 1543
2015
Q4
$88K Buy
24,997
+176
+0.7% +$737 ﹤0.01% 1597
2015
Q3
$125K Buy
24,821
+3,548
+17% +$20.3K ﹤0.01% 1558
2015
Q2
$137K Buy
21,273
+3,273
+18% +$21.9K ﹤0.01% 1519
2015
Q1
$127K Buy
18,000
+1,400
+8% +$10.1K ﹤0.01% 1527
2014
Q4
$128K Buy
16,600
+796
+5% +$6.3K ﹤0.01% 1512
2014
Q3
$118K Sell
15,804
-5,327
-25% -$49.5K ﹤0.01% 1559
2014
Q2
$205K Buy
21,131
+1,739
+9% +$15.5K ﹤0.01% 1496
2014
Q1
$161K Sell
19,392
-4,041
-17% -$34.6K ﹤0.01% 1532
2013
Q4
$198K Buy
23,433
+12,104
+107% +$102K ﹤0.01% 1525
2013
Q3
$90K Buy
+11,329
New +$91.1K ﹤0.01% 1626

Other funds holding PDLI

Ohio Public Employees Retirement System (OPERS)'s PDLI Position: Q4 2020 in Review

Ohio Public Employees Retirement System (OPERS) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 23,905 shares — an estimated $75K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in PDLI in Q3 2013 and held it in 29 quarters. The position peaked at $539K in Q3 2016. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 23,905 PDL BioPharma, Inc. shares in Q4 2020, an estimated $75K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 29 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s PDL BioPharma, Inc. position peaked at $539K in Q3 2016.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2020, filed 12 Feb 2021.